← All Sponsors
SPONSOR

Antengene Therapeutics Limited

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Locally Advanced or Metastatic Solid Tumors
NCT05205109 Phase 1
Recruiting

A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors

Locally Advanced or Metastatic Solid Tumors
Australia, China View Trial →